|
Princeton Docket #
07-2347
Researchers in
Electrical Engineering and Molecular Biology, Princeton University have
developed new levels of controlled
differentiation in embryonic stem cells that are well-beyond existing
technologies. The proposed approach will lead to new opportunities and
strategies in many different biomedical therapies, such...
Published: 3/15/2018
|
Inventor(s): Ronald Weiss, Ihor Lemischka, Christoph Schaniel
Keywords(s): diabetes, stem cell
Category(s): Biotechnology/Pharmaceuticals
|
|
Researchers at
Princeton University have developed methods useful in genetic high-throughput
screens (HTS) of alternative splice variants. More specifically, the developed
technology can be applied for massive functional identification of splice
variants whose misexpression can promote cancerous cell transformation or induce
stem cell differentiation...
Published: 3/15/2018
|
Inventor(s): Ihor Lemischka, Moshe Pritsker
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|
|
Princeton
University Invention # 05-2180
Molecular
mechanisms regulating the identity of stem cells and their balance of
self-renewal and differentiation are critical for proper tissue development of
every organism and the development of regenerative cell therapies. Embryonic
stem cell-based therapies bear some potential but are very controversial....
Published: 3/15/2018
|
Inventor(s): Ihor Lemischka, Christoph Schaniel, Feng Li, Xenia Schafer
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|
|
Researchers at Princeton University have developed methods useful in
large-scale probing of interactions between genes and their products. More
specifically, the new technology is useful for a systematic parallel analysis of
genetic and protein-protein interactions on a genome-wide scale. For example,
the developed technology can be applied for...
Published: 3/15/2018
|
Inventor(s): Ihor Lemischka, Moshe Pritsker
Keywords(s):
Category(s): Biotechnology/Pharmaceuticals
|